COMP2020 - Cardio-Oncology Multidisciplinary Practice Inaugural Conference is organized by The University of Texas MD Anderson Cancer Center and will be held from Jan 17 - 18, 2020 at The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
This program should be of value to Physicians, Advanced Practice Providers, Nurses and Pharmacists.
The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 12.75 AMA PRA Category 1 CreditsTM.
The Supportive Care/End-of-Life presentation has been designated by The University of Texas MD Anderson Cancer Center for .50 AMA PRA Category 1 CreditsTM in medical ethics and/or professional responsibility.
Successful completion of this conference will provide up to 12.00 contact hours, which will include 2.6 Pharmaceutical credits for those sessions attended.
This activity is being planned for an audience of both cardiology and oncology physicians, advanced practice providers, nurses and pharmacists. Cardiovascular disease and cancer are the number 1 and 2 causes of death respectively in the United States. Both cardiology and oncology are rapidly evolving fields that often do not intersect in terms of their educational and training programs. With the development of new targeted cancer therapeutics all with unique cardiovascular toxicities, health care providers must be knowledgeable of both. There is not a consensus on how to diagnose, monitor, or even treat cardiovascular side effects of cancer and cancer therapeutics. This activity is designed to update health care providers on the new cancer therapeutics and a practical approach to diagnosing and treating the cardiovascular adverse events. The expected outcome will be that healthcare providers at other institutions and in the community will be able to recognize and manage cardiovascular disease in cancer patients more effectively.
• Demonstrate comprehensive knowledge of the cardiovascular toxicities from traditional chemotherapeutics and newer targeted cancer therapies (Knowledge, Competence, Patient Outcomes)
• Utilize cardiovascular imaging modalities for monitoring and diagnosing cancer therapeutic cardiotoxicity (Knowledge, Competence, Performance, Patient Outcomes)
• Practice routine treatment of cardiac disease concurrently during cancer diagnosis and therapy (Knowledge, Competence, Performance, Patient Outcomes)
• Diagnose and manage pericardial disease in the cancer patient (Knowledge, Competence, Performance, Patient Outcomes)
• Manage cardiac arrhythmias and devices in a specialized way specific to the cancer patient (Knowledge, Competence, Performance, Patient Outcomes)
Additional details will be posted as soon as information is available.
|Contact No. :||713-794-7124
|Registration Type||End Date||Price|
|Physicians - Early Fee||27 Dec,2019||USD 275.00|
|Physicians - Conference Fee||16 Jan,2020||USD 325.00|
|APPs/Nurses/Trainees - Early Fee||27 Dec,2019||USD 200.00|
|APPs/Nurses/Trainees - Conference Fee||16 Jan,2020||USD 250.00|
|MD Anderson Network Physicians - Early Fee||27 Dec,2019||USD 250.00|
|MD Anderson Network Physicians - Conference Fee||16 Jan,2020||USD 300.00|
|MD Anderson Network APPs/Nurses/Trainees - Early Fee||27 Dec,2019||USD 175.00|
|MD Anderson Network APPs/Nurses/Trainees - Conference Fee||16 Jan,2020||USD 225.00|
The University of Texas MD Anderson Cancer Center
Duncan Building, CPB, Conference Center, Floor 8, 1155 Pressler Street
Houston, Texas, United States of America
Houston Marriott Medical Center/Museum District,
6580 Fannin St,
Houston, Texas, United States of America 77030,